In vitro drug combination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil with anti-human immunodeficiency virus or anticancer nucleosides.

1-beta-D-Arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and E-5-(2-bromovinyl)uracil, a metabolite of BV-araU, did not affect either the anti-human immunodeficiency virus activity or the cytotoxicity of azidothymidine in MT-4 and MOLT-4 cells. Similarly, the bromovinyl compounds did not affect...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Machida, H, Ashida, N, Ikeda, T, Sakata, S, Baba, M, Shigeta, S
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1992
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189263/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1317147/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.1.214
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!